Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

BlackRock, Inc. reported a 6.30% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 4, 2025

BlackRock, Inc. reported a 6.30% stake in Monte Rosa Therapeutics, Inc., 3,840,165 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G).

Stake
6.30%
Shares
3,840,165
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.6.30%3,840,165

Source

View original at SEC

Related